Correction to: Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?

Journal

PharmacoEconomics
ISSN: 1179-2027
Titre abrégé: Pharmacoeconomics
Pays: New Zealand
ID NLM: 9212404

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 11 3 2019
medline: 11 3 2019
entrez: 11 3 2019
Statut: ppublish

Résumé

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0International License.

Identifiants

DOI: 10.1007/s40273-018-00763-4 PMID: 30852811 PMC: PMC6830395
pubmed: 30852811
doi: 10.1007/s40273-018-00763-4
pii: 10.1007/s40273-018-00763-4
pmc: PMC6830395
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

969

Commentaires et corrections

Type : ErratumFor

Auteurs

Paul Mark Mitchell (PM)

Health Economics at Bristol (HEB), School of Social and Community Medicine, University of Bristol, Bristol, UK. paul.mitchell@bristol.ac.uk.
The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West), University Hospitals Bristol NHS Foundation Trust, Bristol, UK. paul.mitchell@bristol.ac.uk.
UK Renal Registry, Southmead Hospital, Bristol, UK. paul.mitchell@bristol.ac.uk.

Sridhar Venkatapuram (S)

Department of Global Health and Social Medicine, King's College London, London, UK.

Jeff Richardson (J)

Centre for Health Economics, Monash University, Melbourne, VIC, Australia.

Angelo Iezzi (A)

Centre for Health Economics, Monash University, Melbourne, VIC, Australia.

Joanna Coast (J)

Health Economics at Bristol (HEB), School of Social and Community Medicine, University of Bristol, Bristol, UK.
The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West), University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Classifications MeSH